Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides

References

• YangY-HYangJJiangQ-HHypolipidemic effect of gypenosides in experimentally induced hypercholesterolemic ratsLipids Health Dis20131211623295061
   PubMedGoogle Scholar
• LiuJ-SChiangT-HWangJ-SInduction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosidesJ Cell Mol Med20151971697170925781909
   PubMed Web of Science ®Google Scholar
• ShiLPiYLuoCZhangCTanDMengXIn vitro inhibitory activities of six gypenosides on human liver cancer cell line HepG2 and possible role of HIF-1α pathway in themChem Biol Interact2015238485426054451
   PubMed Web of Science ®Google Scholar
• MuR-HFangX-YWangS-SAntidepressant-like effects of standardized gypenosides: involvement of brain-derived neu-rotrophic factor signaling in hippocampusPsychopharmacology2016233173211322127385417
   PubMedGoogle Scholar
• ChenM-HChenS-HWangQ-FThe molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cellsJ Ethnopharmacol2008117230931718372131
   PubMedGoogle Scholar
• YuHGuanQGuoLGypenosides alleviate myocardial ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function in rat heartCell Stress Chaperones201621342943726800973
   PubMed Web of Science ®Google Scholar
• YuFPreparation, characteristics and bioactivity of Gypenosides-Loaded microcapsulesAdv Mat Res2013710195198
   Google Scholar
• YuYLuYBoRThe preparation of gypenosides liposomes and its effects on the peritoneal macrophages function in vitroInt J Pharm20144601–224825424269288
   PubMed Web of Science ®Google Scholar
• BeloquiASolinísMaría ÁRodríguez-GascónAAlmeidaAJPréatVNanostructured lipid carriers: promising drug delivery systems for future clinicsNanomedicine201612114316126410277
   PubMed Web of Science ®Google Scholar
• LuanJZhengFYangXYuAZhaiGNanostructured lipid carriers for oral delivery of baicalin: in vitro and in vivo evaluationColloids Surf A2015466154159
   Web of Science ®Google Scholar
• ChenZLaiXSongSZhuXZhuJNanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapyDrug Deliv20162341369137326017099
   PubMed Web of Science ®Google Scholar
• KhanSBabootaSAliJNarangRSNarangJKChlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluationDrug Dev Ind Pharm201642220922026016780
   PubMed Web of Science ®Google Scholar
• RogerELagarceFGarcionEBenoitJ-PBiopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral deliveryNanomedicine20105228730620148639
   PubMed Web of Science ®Google Scholar
• MudieDMAmidonGLAmidonGEPhysiological parameters for oral delivery and in vitro testingMol Pharm2010751388140520822152
   PubMed Web of Science ®Google Scholar
• ZhangZGaoFJiangSBile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in ratsInt J Pharm20134521–237438123694804
   PubMedGoogle Scholar
• NiuMLuYHovgaardLWuWLiposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro char-acterization, and improved protection against enzymatic degradationInt J Nanomedicine201161155116621822379
   PubMed Web of Science ®Google Scholar
• YangGZhaoYZhangYDangBLiuYFengNEnhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivoInt J Nanomedicine2015106633664426543366
   PubMed Web of Science ®Google Scholar
• GuanPLuYQiJEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomedicine2011696597421720508
   PubMed Web of Science ®Google Scholar
• SeniorKBilosomes: the answer to oral vaccine delivery?Drug Discov Today20016201031103211590024
   PubMed Web of Science ®Google Scholar
• MikovMFawcettJPKuhajdaKKevresanSPharmacology of bile acids and their derivatives: absorption promoters and therapeutic agentsEur J Drug Metab Pharmacokinet200631323725117136862
   PubMed Web of Science ®Google Scholar
• SanapGSDesign and evaluation of miconazole nitrate loaded nano-structured lipid carriers (NLC) for improving the antifungal therapyJ App Pharm Sci20133112
   Google Scholar
• SinghPAryaMKanoujiaJSinghMGuptaKPSarafSADesign of topical nanostructured lipid carrier of silymarin and its effect on 7,12-dimethylbenz[a]anthracene (DMBA) induced cellular differentiation in mouse skinRSC Advances20166888496584977
   Web of Science ®Google Scholar
• RahmanHSRasedeeAHowCWZerumbone-loaded nano-structured lipid carriers: preparation, characterization, and antileukemic effectInt J Nanomedicine201382769278123946649
   PubMed Web of Science ®Google Scholar
• ZhouXZhangXYeYNanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorptionInt J Pharm2015479239139825556104
   PubMed Web of Science ®Google Scholar
• DesaiMPLabhasetwarVWalterELevyRJAmidonGLThe mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependentPharm Res19971411156815739434276
   PubMed Web of Science ®Google Scholar
• ChenYYuanLZhouLZ-HaiZhangCaoWWuQEffect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterineInt J Nanomedicine2012744581459122942642
   PubMedGoogle Scholar
• SiekmannBWestesenKMelt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol I. Preparation and particle size determinationPharm Pharmacol Lett19943194197
   Google Scholar
• de CarvalhoSMNoronhaCMFlorianiCLOptimization of α-tocopherol loaded solid lipid nanoparticles by central composite designInd Crops Prod201349278285
   Web of Science ®Google Scholar
• HejriAKhosraviAGharanjigKHejaziMOptimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion methodFood Chem2013141111712323768336
   PubMed Web of Science ®Google Scholar
• ZhangJFanYSmithEExperimental design for the optimization of lipid nanoparticlesJ Pharm Sci20099851813181918781636
   PubMed Web of Science ®Google Scholar
• JainKSoodSGowthamarajanKOptimization of artemether-loaded NLC for intranasal delivery using central composite designDrug Deliv201522794095424512368
   PubMed Web of Science ®Google Scholar
• dasSNgWKTanRBHAre nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?Eur J Pharm Sci201247113915122664358
   PubMed Web of Science ®Google Scholar
• QianCMcClementsDJFormation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle sizeFood Hydrocolloids201125510001008
   Web of Science ®Google Scholar
• WangFChenLJiangSOptimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken designJ Liposome Res201424317118124611687
   PubMed Web of Science ®Google Scholar
• KudarhaRDhasNLPandeyABelgamwarVSIgePPBox-Behnken study design for optimization of bicalutamide-loaded nano-structured lipid carrier: stability assessmentPharm Dev Technol201520560861824785784
   PubMed Web of Science ®Google Scholar
• ElnaggarYSREl-MassikMAAbdallahOYFabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticlesInt J Nanomedicine2011663195320522238508
   PubMedGoogle Scholar
• SofouSRadionuclide carriers for targeting of cancerInt J Nanomedicine20083218119918686778
   PubMed Web of Science ®Google Scholar
• Al-HilalTAChungSWAlamFFunctional transformations of bile acid transporters induced by high-affinity macromoleculesSci Rep20154141634179
   Google Scholar
• MahmudFJeonO-CAl-HilalTAAbsorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small IntestineMol Pharm20151261911192025892399
   PubMedGoogle Scholar
• Al-HilalTAAlamFByunYOral drug delivery systems using chemical conjugates or physical complexesAdv Drug Deliv Rev201365684586423220326
   PubMed Web of Science ®Google Scholar
• MeaneyCMO’DriscollCMA comparison of the permeation enhancement potential of simple bile salt and mixed bile salt: fatty acid micel-lar systems using the CaCo-2 cell culture modelInt J Pharm20002071–2213011036226
   PubMedGoogle Scholar
• HuSNiuMHuFIntegrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal mediaInt J Pharm20134411–269370023089580
   PubMed Web of Science ®Google Scholar
• NiuMYa’nanTanGuanPEnhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic studyInt J Pharm20144601–211913024275447
   PubMed Web of Science ®Google Scholar
• NishimuraHHayashiCAibaTApplication of the correlation of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for Soft-Gel Capsules – a Pointless pursuit?Biol Pharm Bull200730112221222517978506
   PubMedGoogle Scholar
• LiXUeharaSSawangratKImprovement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancementInt J Pharm20185351–234034929157961
   PubMed Web of Science ®Google Scholar